The pharmacokinetics of Norpace
Karim, A.
Angiology 26(1 Part 2): 85-98
1975
ISSN/ISBN: 0003-3197 PMID: 1090217 Document Number: 87873
Document emailed within 1 workday
Related Documents
Dreifus, L.S. 1975: Clinical studies of Norpace (Part X) Angiology 26(1 Part 2): 148Kalmansohn, R.G. 1975: Clinical studies of Norpace (Part III) Angiology 26(1 Part 2): 137
Smith, W.S. 1975: Clinical studies of Norpace (Part I) Angiology 26(1 Part 2): 124-131
Agre, K. 1981: Corrected data on disopyramide phosphate (Norpace) Geriatrics 36(7): 139
Smith, W.S. 1978: Clinical studies of the antiarrhythmic efficacy of disopyramide phosphate (Norpace) Herz 63(36): 399-406
Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
Yamamoto, N.; Yanagi, K.; Matuyama, H.; Shimizu, K.; Mitsui, H.; Shimabukuro, T.; Yamamoto, M.; Sakatoku, J.; Fujita, T.; Matsuoka, K. 1987: Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule) Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1760-1765
Liu, M.J.; Brouwer, K.L.; Pollack, G.M. 1992: Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat Drug Metabolism and Disposition: the Biological Fate of Chemicals 20(6): 810-815
Pannuti, F.; Coppi, G.; Borella, F.; Martoni, A.; Urbano, L.; Melotti, B. 1988: Pharmacokinetics of PTT-119 in man Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(2): 113-116
Al-Tahan, F.; Löscher, W.; Frey, H.H. 1984: Pharmacokinetics of clonazepam in the dog Archives Internationales de Pharmacodynamie et de Therapie 268(2): 180-193
Harvengt, C.; Desager, J.P. 1980: Pharmacokinetics of fenofibrate in man La Nouvelle Presse Medicale 9(49): 3725-3727
Hitzenberger, G. 1981: Pharmacokinetics of ceftizoxim Wiener Medizinische Wochenschrift 131(15-16): 391-394
Wildfeuer, A.; Lemme, J.D. 1985: The pharmacokinetics of josamycin Arzneimittel-Forschung 35(3): 639-643
Grafnetterová, J.; Janků, I.; König, J.; Krebs, V.; Ackerman, R. 1982: Pharmacokinetics of Damvar Neoplasma 29(2): 223-232
Kalabukhova, N.F. 1973: Ampicillin pharmacokinetics Antibiotiki 18(5): 416-420
Sergeeva, S.A.; Krasnykh, L.M. 1994: The pharmacokinetics of adamantanes Eksperimental'naia i Klinicheskaia Farmakologiia 57(3): 69-74
Hale, V.G.; Bashaw, E.D. 1993: Pharmacokinetics of oxaprozin Clinical Pharmacy 12(4): 255-256